MDR1 - Multidrug Resistance 1 evg-analysen CMR3 is predicted to be

CMR3 is predicted to be based on a distinctly different molecular mechanism

First significant symptoms usually manifest at approximately 12-17 months and severe decline in neurological function set in between 18-23 months of age

Even untested dogs from susceptible breeds should be treated with caution

metabolic acidosis is moderate and muscle rigidity is minimal

a glycoprotein that helps with blood clotting

MDR1 - Multidrug Resistance 1 evg-analysen CMR3 is predicted to beMultidrug resistance 1 or drug intolerance, MDR1 for short, is a congenital disease that occurs in many herding dog breeds. The mutation in the ABCB1 gene causes a malfunction of the P glycoprotein, which is responsible for the breakdown of certain drugs and toxins in the body. Clinical symptoms are often associated with the distribution of drugs in the central nervous system. Based on reports that even carriers can develop symptoms of intolerance, it